Assessing the impact of COVID-19 on liver cancer management (CERO-19)

JHEP Reports(2021)

引用 37|浏览19
暂无评分
摘要
•The coronavirus disease 2019 (COVID-19) pandemic had a worldwide impact on liver cancer management.•Screening programmes were modified or cancelled in 80.9% of participating centres.•All but systemic treatments were cancelled or delayed in almost all centres.•Phone call visits were the tools for patient follow-up during the first wave.•The role of the nurses was key to maintaining clinical practice and clinical trials.
更多
查看译文
关键词
COVID-19,Hepatocellular carcinoma,Cholangiocarcinoma,Liver cancer,Management,Clinical trials,Nurses
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要